Suppr超能文献

时间性肠道微生物变化可预测溃疡性结肠炎和非溃疡性结肠炎患者复发性艰难梭菌感染。

Temporal Gut Microbial Changes Predict Recurrent Clostridiodes Difficile Infection in Patients With and Without Ulcerative Colitis.

机构信息

Division of Gastroenterology, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI.

Division of Infectious Diseases, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI.

出版信息

Inflamm Bowel Dis. 2020 Oct 23;26(11):1748-1758. doi: 10.1093/ibd/izz335.

Abstract

BACKGROUND

Ulcerative colitis (UC) carries an increased risk of primary and recurrent Clostridiodes difficile infection (rCDI), and CDI is associated with UC flares. We hypothesized that specific fecal microbial changes associate with UC flare and rCDI.

METHODS

We conducted a prospective observational cohort study of 57 patients with UC and CDI, CDI only, and UC only. Stool samples were collected at baseline, at the end of antibiotic therapy, and after reconstitution for 16S rRNA sequencing. The primary outcomes were recurrent UC flare and rCDI. Logistic regression and Lasso models were constructed for analysis.

RESULTS

There were 21 (45.7%) patients with rCDI, whereas 11 (34.4%) developed UC flare. Patients with rCDI demonstrated significant interindividual (P = 0.008) and intraindividual differences (P = 0.004) in community structure by Jensen-Shannon distance (JSD) compared with non-rCDI. Two cross-validated Lasso regression models predicted risk of rCDI: a baseline model with female gender, hospitalization for UC in the past year, increased Ruminococcaceae and Verrucomicrobia, and decreased Eubacteriaceae, Enterobacteriaceae, Lachnospiraceae, and Veillonellaceae (AuROC, 0.94); and a model 14 days after completion of antibiotics with female gender, increased Shannon diversity, Ruminococcaceae and Enterobacteriaceae, and decreased community richness and Faecalibacterium (AuROC, 0.9). Adding JSD between baseline and post-treatment samples to the latter model improved fit (AuROC, 0.94). A baseline model including UC hospitalization in the past year and increased Bacteroidetes was associated with increased risk for UC flare (AuROC, 0.88).

CONCLUSION

Fecal microbial features at baseline and after therapy predict rCDI risk in patients with and without UC. These results may help risk stratify patients to guide management.

摘要

背景

溃疡性结肠炎(UC)发生原发性和复发性艰难梭菌感染(rCDI)的风险增加,而 CDI 与 UC 发作有关。我们假设特定的粪便微生物变化与 UC 发作和 rCDI 相关。

方法

我们对 57 例 UC 合并 CDI、单纯 CDI 和单纯 UC 患者进行了前瞻性观察队列研究。在基线、抗生素治疗结束时和重新定植后采集粪便样本进行 16S rRNA 测序。主要结局是 rCDI 后 UC 复发和 rCDI。构建逻辑回归和套索模型进行分析。

结果

21 例(45.7%)患者发生 rCDI,11 例(34.4%)发生 UC 发作。与非 rCDI 相比,rCDI 患者的个体间(P=0.008)和个体内(P=0.004)的群落结构差异明显(Jensen-Shannon 距离,JSD)。两个交叉验证的套索回归模型预测 rCDI 风险:一个基于基线的模型,包括女性、过去 1 年因 UC 住院、瘤胃球菌科和疣微菌科增加、真杆菌科、肠杆菌科、毛螺菌科和韦荣球菌科减少(AUROC,0.94);另一个是抗生素治疗结束后 14 天的模型,包括女性、Shannon 多样性增加、瘤胃球菌科和肠杆菌科增加、群落丰富度和粪杆菌减少(AUROC,0.9)。将基线和治疗后样本之间的 JSD 添加到后一个模型中可以提高拟合度(AUROC,0.94)。一个包括过去 1 年 UC 住院和 Bacteroidetes 增加的基线模型与 UC 发作风险增加相关(AUROC,0.88)。

结论

基线和治疗后粪便微生物特征可预测 UC 合并和不合并 CDI 患者的 rCDI 风险。这些结果可能有助于对患者进行风险分层,以指导治疗。

相似文献

4
Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles.
Aliment Pharmacol Ther. 2016 Jun;43(11):1142-53. doi: 10.1111/apt.13616. Epub 2016 Apr 18.
5
Fecal microbiota transplantation for treatment of patients with recurrent infection.
Expert Rev Anti Infect Ther. 2020 Jul;18(7):669-676. doi: 10.1080/14787210.2020.1752192. Epub 2020 Apr 12.
6
Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.
BMC Infect Dis. 2019 Apr 30;19(1):361. doi: 10.1186/s12879-019-3965-8.
7
Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.
PLoS One. 2013 Nov 26;8(11):e81330. doi: 10.1371/journal.pone.0081330. eCollection 2013.
8
Genetic risk factors for Clostridium difficile infection in ulcerative colitis.
Aliment Pharmacol Ther. 2013 Sep;38(5):522-30. doi: 10.1111/apt.12425. Epub 2013 Jul 14.
10
Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection.
Dig Dis Sci. 2018 Jul;63(7):1801-1810. doi: 10.1007/s10620-018-5044-1. Epub 2018 Apr 12.

引用本文的文献

1
Comprehensive proteomic profiling of intestinal tissues in patients with ulcerative colitis.
Front Med (Lausanne). 2025 Jun 13;12:1537168. doi: 10.3389/fmed.2025.1537168. eCollection 2025.
4
Modeling microbiome-trait associations with taxonomy-adaptive neural networks.
Microbiome. 2025 Mar 29;13(1):87. doi: 10.1186/s40168-025-02080-3.
6
Faecalibacterium: a bacterial genus with promising human health applications.
FEMS Microbiol Rev. 2023 Jul 5;47(4). doi: 10.1093/femsre/fuad039.
7
Gut microbiota changes associated with infection and its various treatment strategies.
Gut Microbes. 2023 Jan-Dec;15(1):2223345. doi: 10.1080/19490976.2023.2223345.
8
Impact of recurrent hospitalization for on longitudinal outcomes in patients with inflammatory bowel diseases: a nationally representative cohort.
Therap Adv Gastroenterol. 2022 Dec 8;15:17562848221141501. doi: 10.1177/17562848221141501. eCollection 2022.
9
Assessing the effect of interaction between gut microbiome and inflammatory bowel disease on the risks of depression.
Brain Behav Immun Health. 2022 Nov 21;26:100557. doi: 10.1016/j.bbih.2022.100557. eCollection 2022 Dec.
10
The role of the gut microbiome in colonization resistance and recurrent infection.
Therap Adv Gastroenterol. 2022 Nov 18;15:17562848221134396. doi: 10.1177/17562848221134396. eCollection 2022.

本文引用的文献

1
Rethinking gut microbiome residency and the Enterobacteriaceae in healthy human adults.
ISME J. 2019 Sep;13(9):2306-2318. doi: 10.1038/s41396-019-0435-7. Epub 2019 May 14.
5
Dynamics of the human gut microbiome in inflammatory bowel disease.
Nat Microbiol. 2017 Feb 13;2:17004. doi: 10.1038/nmicrobiol.2017.4.
6
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Cell Mol Gastroenterol Hepatol. 2016 Mar 3;2(4):468-481. doi: 10.1016/j.jcmgh.2016.02.003. eCollection 2016 Jul.
8
Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection.
Aliment Pharmacol Ther. 2016 Oct;44(7):715-727. doi: 10.1111/apt.13750. Epub 2016 Aug 2.
10
Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938.
Anaerobe. 2016 Aug;40:95-9. doi: 10.1016/j.anaerobe.2016.06.008. Epub 2016 Jun 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验